60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) Short Interest Update

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 984 shares, an increase of 92.6% from the December 31st total of 511 shares. Based on an average daily trading volume, of 1,002 shares, the short-interest ratio is presently 1.0 days. Based on an average daily trading volume, of 1,002 shares, the short-interest ratio is presently 1.0 days.

60 Degrees Pharmaceuticals Trading Down 27.6%

NASDAQ:SXTPW traded down $0.02 during trading hours on Friday, reaching $0.06. 6,459 shares of the stock were exchanged, compared to its average volume of 12,220. The firm has a 50 day simple moving average of $0.06 and a 200-day simple moving average of $0.06. 60 Degrees Pharmaceuticals has a 52 week low of $0.02 and a 52 week high of $0.16.

60 Degrees Pharmaceuticals Company Profile

60 Degrees Pharmaceuticals, Inc operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue.